Top Senate Democrat: The House Intel Memo Is Sloppy And

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28 Bhawks #7901
136
Top Senate Democrat: The House Intel Memo Is Sloppy And Baseless. Also, I’ve Not Read It

He must be related to Nancy Pelosi? LOL

http://thefederalist.com/2018/01/25/top-senat...D9.twitter

Sen. Mark Warner (D-Va.) said Wednesday that the classified report compiled by the House Intelligence Committee, which reportedly details abuses by federal law enforcement and surveillance agencies, is “sloppy” and “baseless.” He also has not read the memo.

“I have not seen the memo,” Warner said, according to CNN. “But I think it is sloppy, careless, and again, I think has no grounding in fact.”

The senior senator form Virginia did not explain how he could know intricate details about a document he has not even read.

Under the rules of the U.S. House and the committee motion to make the report available to the entire House, only members of the House have been authorized to read the four-page classified memo. Before the memo can be made available to Senators and their staffs, executive branch agencies like the FBI, and the general public, the committee must vote to make the report publicly available. Congressional Democrats have repeatedly said they oppose making the report available to the public. Rep. Adam Schiff (D-Calif.), the top Democrat on the House Intelligence Committee, has said that the American public doesn’t have the necessary knowledge or experience to adequately understand the findings in the report and should therefore be denied access to it.

The memo, which has stoked both widespread speculation and outrage in Washington, reportedly contains information about the FBI’s reliance on a now-infamous dossier compiled by British ex-spy Christopher Steele to obtain a warrant from a Foreign Intelligence Surveillance Court to spy on associates of the Trump presidential campaign. To date, none of the dossier’s substantive allegations of illegal foreign collusion have been independently verified.

Steele, who has not set foot in Russia in nearly two decades, relied on information he received third-hand, including from Kremlin-connected Russians who may have used Steele to peddle disinformation in order to interfere with the 2016 presidential elections in the U.S. This dossier was funded in part by the Democratic National Committee, Hillary Clinton, and possibly others. The firm that commissioned the dossier, Fusion GPS, was at the same time working on behalf of a Russian company accused by the U.S. government of fraud and money laundering as part of a scheme to violate U.S. sanctions against corrupt Russians.

Republican lawmakers in the House are currently considering if, when, and how to make the House report available to the public. Under House rules, if the president objects in writing to the release of the report, a majority vote by the full House of Representatives is necessary to make the report public. Absent a presidential objection, the House Intelligence Committee can release the memo by majority vote.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 268

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 186

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 174

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 170

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 224

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
BETR's Slide: Investors Face Big Losses, Leadership Shift

Updated Category News Views 92

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Continue Reading

Top 5 Most Recently Viewed Articles

Paratus Welcomes New Chief Commercial Officer for Growth

Updated Category News Views 291

Paratus Strengthens Leadership with New Appointment In a significant strategic move, Paratus Holdings Limited has appointed Taraneh Azad as their new Chief Commercial Officer. This decision comes as the company aims to refine its commercial strategy while forming vital partnerships across various sectors. Meet Taraneh Azad Taraneh Azad is a well-respected figure in the...

Continue Reading
Banco Comercial Português Updates on Share Buy-Back Programme

Updated Category News Views 186

Banco Comercial Português Announces Share Buy-Back Programme Report Banco Comercial Português, S.A. has provided an important update regarding its Share Buy-Back Programme. This report highlights the activities undertaken within the scope of the program, reflecting the bank's ongoing commitment to enhancing shareholder value. Understanding the Share Buy-Back Programme...

Continue Reading
Unitil Enhances Operations with Bangor Natural Gas Acquisition

Updated Category News Views 220

Unitil Completes Strategic Acquisition of Bangor Natural Gas Unitil Corporation (NYSE:UTL) has taken a significant step in strengthening its position in the energy sector by completing the purchase of Bangor Natural Gas Company. The successful acquisition, concluded recently, paves the way for Unitil to increase its customer base and enhance service delivery across the...

Continue Reading
ISS A/S Announces Strategic Share Buyback Details

Updated Category News Views 92

Overview of Share Buyback Programme ISS A/S, a prominent player in workplace experience and facility management, recently revealed significant updates regarding its share buyback programme. Following an earlier announcement regarding this initiative, ISS A/S plans to redistribute excess cash back to its loyal shareholders. This strategy aligns with their goal to reduce...

Continue Reading
bluebird bio Enhances Access to Gene Therapy with CMMI Agreement

Updated Category News Views 325

bluebird bio and CMMI: A New Era in Gene Therapy Access bluebird bio, Inc. (NASDAQ: BLUE) is making notable strides in the field of gene therapy as it has recently entered into a significant partnership with the Center for Medicare and Medicaid Innovation (CMMI). This collaboration aims to enhance the accessibility of LYFGENIA, a gene therapy specifically designed for...

Continue Reading